Shares of Kewaunee Scientific Corporation (NASDAQ:KEQU - Get Free Report) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $47.35 and traded as high as $55.04. Kewaunee Scientific shares last traded at $54.80, with a volume of 99,113 shares changing hands.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen downgraded shares of Kewaunee Scientific from a "buy" rating to a "hold" rating in a research report on Friday, March 14th.
Check Out Our Latest Report on Kewaunee Scientific
Kewaunee Scientific Stock Up 35.4%
The company's fifty day simple moving average is $36.60 and its 200-day simple moving average is $47.35. The firm has a market capitalization of $156.18 million, a PE ratio of 14.31 and a beta of 0.56. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.16 and a quick ratio of 1.54.
Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last posted its quarterly earnings data on Wednesday, June 25th. The technology company reported $1.95 earnings per share for the quarter. Kewaunee Scientific had a return on equity of 26.69% and a net margin of 4.74%. The firm had revenue of $77.15 million during the quarter.
Insider Transactions at Kewaunee Scientific
In other news, CEO Thomas David Hull III sold 1,844 shares of the stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $32.44, for a total value of $59,819.36. Following the transaction, the chief executive officer now directly owns 36,072 shares of the company's stock, valued at approximately $1,170,175.68. This represents a 4.86% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Donald T. Gardner III sold 3,000 shares of the firm's stock in a transaction dated Wednesday, April 9th. The stock was sold at an average price of $37.75, for a total value of $113,250.00. Following the completion of the transaction, the chief financial officer now owns 15,358 shares of the company's stock, valued at approximately $579,764.50. The trade was a 16.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 14.20% of the company's stock.
Institutional Investors Weigh In On Kewaunee Scientific
Large investors have recently bought and sold shares of the company. Bank of America Corp DE raised its position in Kewaunee Scientific by 2,605.9% during the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock worth $28,000 after buying an additional 443 shares during the last quarter. IFP Advisors Inc purchased a new stake in shares of Kewaunee Scientific in the 4th quarter valued at $36,000. Morgan Dempsey Capital Management LLC acquired a new stake in shares of Kewaunee Scientific in the fourth quarter worth $106,000. Wedbush Securities Inc. purchased a new position in shares of Kewaunee Scientific during the fourth quarter worth $262,000. Finally, OMERS ADMINISTRATION Corp acquired a new position in Kewaunee Scientific during the first quarter valued at $284,000. Hedge funds and other institutional investors own 32.69% of the company's stock.
About Kewaunee Scientific
(
Get Free Report)
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kewaunee Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kewaunee Scientific wasn't on the list.
While Kewaunee Scientific currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
